The Effects of Dipeptidyl Peptidase 4 Inhibitors on Renal Function in Patients with Type 2 Diabetes Mellitus

Past studies have confirmed that glucagon-like peptide 1 (GLP-1) receptor agonists can improve renal outcomes in patients with type 2 diabetes mellitus (DM). This study aimed to evaluate whether dipeptidyl peptidase 4 (DPP-4) inhibitors, which elevate GLP-1 levels, also have similar effects on renal...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Wan-Chia, Lin, Chun-Sheng, Chen, Jung-Fu, Chang, Chih-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101888/
https://www.ncbi.nlm.nih.gov/pubmed/35566779
http://dx.doi.org/10.3390/jcm11092653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101888/
https://www.ncbi.nlm.nih.gov/pubmed/35566779
http://dx.doi.org/10.3390/jcm11092653

Ejemplares similares